Placeholder

Special Feature: Good Citizens

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 1328. Categories: , .

Product Description

The pharmaceutical industry comes under a great deal of criticism from politicians and the general public, but much of the value companies offer to society is misunderstood or goes largely unnoticed. This includes the donations made by many companies, from large-scale drug donations in many developing nations to selling drugs at cost in poorer nations to patient assistance programs abroad and in the United States. But it also extends well beyond these programs into areas not necessarily related to their products or even healthcare.
The companies, profiled in this two-part PharmaVOICE special feature to be published in the May and June issues, have embraced the concept of corporate good citizenship and philanthropy. Many of these companies have dedicated divisions for philanthropy and volunteerism. Amgen, for example, established its Amgen Foundation in 1991 as a vehicle for the company’s numerous philanthropic endeavors, and AstraZeneca and Roche both…

Giving Back (part one) …
Amgen, Thousand Oaks, Calif., is a human therapeutics company in the biotechnology industry. The company’s philanthropic division, The Amgen Foundation seeks to advance science education, improve quality of care and access for patients, and support resources that create sound communities where Amgen staff members live and work. For more information, visit amgen.com.
AstraZeneca, Wilmington, Del., is an international healthcare business engaged in the research, development, manufacture, and marketing of prescription pharmaceuticals and the supply of healthcare services. For more information, visit astrazeneca-us.com.
AVEO Pharmaceuticals, Cambridge, Mass., is a biopharmaceutical company focused on the discovery and development of novel cancer therapeutics. For more information, visit aveopharma.com.
Genzyme Corp., Cambridge, Mass., is a biotechnology company focused on rare inherited disorders, kidney disease, orthopedics, transplant, cancer, and diagnostic testing, and is also conducting research into immune disease, infectious disease, and other areas of unmet medical need. For more information, visit genzyme.com.
Hana Biosciences Inc., South San Francisco, Calif., is a biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to strengthen the foundation of cancer care. For more information, visit hanabiosciences.com.
MedImmune, Gaithersburg, Md., a wholly owned subsidiary of AstraZeneca, is focused on cardiovascular/gastrointestinal disease, neuroscience, oncology, infection, respiratory disease, and inflammation. For more information, visit medimmune.com.
Roche, Nutley, N.J., is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. The company also commits to citizenship efforts, especially in areas surrounding Roche facilities, with the goal of becoming familiar with the social, educational, medical, and other needs that contribute to a healthy community. For more information, visit rocheusa.com.
Shire Pharmaceuticals, Wayne, Pa., focuses on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. For more information, visit shire.com.

FEEDBACK